Lixte Biotechnology Holdings Inc. Revenue 2010–2015
Lixte Biotechnology Holdings Inc. annual/quarterly revenue history and growth rate from 2010 to 2013. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lixte Biotechnology Holdings Inc. revenue for the quarter ending September 30, 2013 was 0.
- Lixte Biotechnology Holdings Inc. revenue for the twelve months ending September 30, 2013 was 0.
- Lixte Biotechnology Holdings Inc. annual revenue for 2015 was 200000.
- Lixte Biotechnology Holdings Inc. annual revenue for 2013 was 0.
- Lixte Biotechnology Holdings Inc. annual revenue for 2012 was 0.
- Lixte Biotechnology Holdings Inc. annual revenue for 2011 was 0.
Lixte Biotechnology Holdings Inc. (LIXT) — Frequently Asked Questions
Lixte Biotechnology Holdings Inc. (LIXT) is a publicly traded US company. It has a market capitalization of $342M. In fiscal 2015 it reported revenue of $200,000 and net income of -$3M. Explore LIXT's stock price, financial statements, earnings history, margins and key ratios below.
What is Lixte Biotechnology Holdings Inc.'s market cap?
Lixte Biotechnology Holdings Inc. (LIXT) has a market capitalization of $342M.
What is the LIXT stock price?
LIXT trades at $7.14 (+3.63% on the day).
How much revenue does Lixte Biotechnology Holdings Inc. make?
Lixte Biotechnology Holdings Inc. reported revenue of $200,000 in fiscal 2015.
Is LIXT profitable?
In fiscal 2015, Lixte Biotechnology Holdings Inc. reported net income of -$3M.